Boston Financial Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $989K | Sell |
2,391
-158
| -6% | -$65.3K | 0.03% | 194 |
|
2024
Q3 | $1.29M | Hold |
2,549
| – | – | 0.04% | 179 |
|
2024
Q2 | $1.24M | Buy |
2,549
+42
| +2% | +$20.5K | 0.04% | 179 |
|
2024
Q1 | $1.35M | Sell |
2,507
-200
| -7% | -$108K | 0.04% | 171 |
|
2023
Q4 | $1.5M | Hold |
2,707
| – | – | 0.05% | 156 |
|
2023
Q3 | $1.18M | Buy |
2,707
+220
| +9% | +$96.2K | 0.04% | 163 |
|
2023
Q2 | $1.25M | Hold |
2,487
| – | – | 0.05% | 171 |
|
2023
Q1 | $1.24M | Sell |
2,487
-3
| -0.1% | -$1.5K | 0.05% | 161 |
|
2022
Q4 | $1.02M | Buy |
2,490
+8
| +0.3% | +$3.26K | 0.04% | 179 |
|
2022
Q3 | $809K | Buy |
2,482
+1
| +0% | +$326 | 0.04% | 184 |
|
2022
Q2 | $870K | Buy |
2,481
+291
| +13% | +$102K | 0.04% | 165 |
|
2022
Q1 | $1.2M | Buy |
2,190
+80
| +4% | +$43.8K | 0.05% | 153 |
|
2021
Q4 | $1.39M | Sell |
2,110
-41
| -2% | -$27K | 0.05% | 133 |
|
2021
Q3 | $1.34M | Buy |
2,151
+15
| +0.7% | +$9.33K | 0.05% | 130 |
|
2021
Q2 | $1.35M | Hold |
2,136
| – | – | 0.05% | 125 |
|
2021
Q1 | $1.05M | Buy |
2,136
+10
| +0.5% | +$4.89K | 0.05% | 126 |
|
2020
Q4 | $1.06M | Hold |
2,126
| – | – | 0.05% | 123 |
|
2020
Q3 | $836K | Sell |
2,126
-57
| -3% | -$22.4K | 0.04% | 134 |
|
2020
Q2 | $721K | Buy |
2,183
+47
| +2% | +$15.5K | 0.04% | 138 |
|
2020
Q1 | $517K | Buy |
2,136
+534
| +33% | +$129K | 0.03% | 157 |
|
2019
Q4 | $418K | Hold |
1,602
| – | – | 0.02% | 185 |
|
2019
Q3 | $436K | Hold |
1,602
| – | – | 0.02% | 190 |
|
2019
Q2 | $441K | Hold |
1,602
| – | – | 0.03% | 192 |
|
2019
Q1 | $358K | Hold |
1,602
| – | – | 0.02% | 211 |
|
2018
Q4 | $298K | Buy |
1,602
+100
| +7% | +$18.6K | 0.02% | 224 |
|
2018
Q3 | $375K | Buy |
1,502
+510
| +51% | +$127K | 0.02% | 231 |
|
2018
Q2 | $216K | Buy |
+992
| New | +$216K | 0.01% | 249 |
|